JULIE SUNDERLAND, Interim CEO
Ms. Julie Sunderland was appointed interim CEO of eGenesis in December 2017, and is also Managing Director at Biomatics Capital Partners. Prior to co-founding Biomatics in 2016, Ms. Sunderland was director of Program Related Investments for the Bill & Melinda Gates Foundation, where she led the foundation’s $1.5 billion strategic investment pool focusing on global health, global development and education. In this role, she funded 50 investments, including 30 in health care, and built a team of 10 investment professionals.
Ms. Sunderland holds a B.A. from Harvard University, an MBA from Wharton Business School and an M.A. from Johns Hopkins School of Advanced International Studies.